Post-acute care (PAC) has emerged as a major strategic concern for health systems as they seek to reduce readmissions, rein in costs, comply with emerging payment models, and improve patient outcomes and satisfaction. In the wake of COVID-19, comprehensive plans and nimble operations are critical to optimally leveraging PAC assets. To succeed going forward, systems must be prepared to elevate their care planning and prioritize the development of strong relationships between acute and PAC providers.
Medical device and other innovative technology advancements hold great promise to improve clinical outcomes. Yet, with an increasing focus on delivering greater value, supply chain leaders and clinicians need to make informed purchasing decisions. Beyond understanding a new technology’s clinical benefits, they need to assess a host of other factors, including cost, reimbursement and contract compliance.
The business model for the typical large hospital or health system depends heavily on a small minority of its total patient population – roughly 10% of all patients who are highly profitable and who subsidize another small but highly unprofitable subset of patients with government coverage or no insurance at all. This article looks back at the Vizient Research Institute’s 2019 study with an eye toward the implications in the wake of the global pandemic.
Hundreds of companies are developing medical artificial intelligence applications with billions of dollars in venture capital. Adoption is in the early stages; helping physicians with image interpretation and diagnostic support. But make no mistake, AI is poised to transform the health care landscape.
This area is reserved for members of the news media. If you qualify, please update your user profile and check the box marked "Check here to register as an accredited member of the news media". Please include any notes in the "Supporting information for media credentials" box. We will notify you of your status via e-mail in one business day.